VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.

VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.

Item
http://www.wikidata.org/entity/Q44788451
Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancerMolecular pathways and therapeutic targets in lung cancerMass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies.VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay.Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?Proteomic biomarkers in lung cancer.Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.The value of proteomics in lung cancer.Impact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small-cell lung cancer.The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.[Research Progress of Biomakers Proteomics-based in Lung Cancer].
P2860

VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.

Item
http://www.wikidata.org/entity/Q44788451
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
VeriStrat® has a prognostic va ...... lysis of SAKK19/05 and NTR528.
@en
VeriStrat® has a prognostic va ...... lysis of SAKK19/05 and NTR528.
@nl
type
label
VeriStrat® has a prognostic va ...... lysis of SAKK19/05 and NTR528.
@en
VeriStrat® has a prognostic va ...... lysis of SAKK19/05 and NTR528.
@nl
prefLabel
VeriStrat® has a prognostic va ...... lysis of SAKK19/05 and NTR528.
@en
VeriStrat® has a prognostic va ...... lysis of SAKK19/05 and NTR528.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
VeriStrat® has a prognostic va ...... alysis of SAKK19/05 and NTR528
@en
P2093
P304
P31
P356
10.1016/J.LUNGCAN.2012.10.006
P433
P478
P50
P577
P698
P921